Global Anti-Cancer Drug Market Professional Survey Report 2019

Table of Contents

Executive Summary

1 Industry Overview of Anti-Cancer Drug

• 1.1 Definition of Anti-Cancer Drug
• 1.2 Anti-Cancer Drug Segment by Type
  • 1.2.1 Global Anti-Cancer Drug Production Growth Rate Comparison by Types (2014-2025)
  • 1.2.2 Avastin
  • 1.2.3 Rituxan
  • 1.2.4 Herceptin
  • 1.2.5 Alimta
• 1.3 Anti-Cancer Drug Segment by Applications
  • 1.3.1 Global Anti-Cancer Drug Consumption Comparison by Applications (2014-2025)
  • 1.3.2 Hospital
  • 1.3.3 Clinic
  • 1.3.4 Home Care
• 1.4 Global Anti-Cancer Drug Overall Market
  • 1.4.1 Global Anti-Cancer Drug Revenue (2014-2025)
  • 1.4.2 Global Anti-Cancer Drug Production (2014-2025)
  • 1.4.3 North America Anti-Cancer Drug Status and Prospect (2014-2025)
  • 1.4.4 Europe Anti-Cancer Drug Status and Prospect (2014-2025)
  • 1.4.5 China Anti-Cancer Drug Status and Prospect (2014-2025)
  • 1.4.6 Japan Anti-Cancer Drug Status and Prospect (2014-2025)
  • 1.4.7 Southeast Asia Anti-Cancer Drug Status and Prospect (2014-2025)
  • 1.4.8 India Anti-Cancer Drug Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis

• 2.1 Raw Material and Suppliers
• 2.2 Manufacturing Cost Structure Analysis of Anti-Cancer Drug
• 2.3 Manufacturing Process Analysis of Anti-Cancer Drug
• 2.4 Industry Chain Structure of Anti-Cancer Drug

3 Development and Manufacturing Plants Analysis of Anti-Cancer Drug

• 3.1 Capacity and Commercial Production Date
• 3.2 Global Anti-Cancer Drug Manufacturing Plants Distribution
• 3.3 Major Manufacturers Technology Source and Market Position of Anti-Cancer Drug
• 3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers

• 4.1 Anti-Cancer Drug Production and Capacity Analysis
• 4.2 Anti-Cancer Drug Revenue Analysis
• 4.3 Anti-Cancer Drug Price Analysis
• 4.4 Market Concentration Degree

5 Anti-Cancer Drug Regional Market Analysis

• 5.1 Anti-Cancer Drug Production by Regions
  • 5.1.1 Global Anti-Cancer Drug Production by Regions
  • 5.1.2 Global Anti-Cancer Drug Revenue by Regions
• 5.2 Anti-Cancer Drug Consumption by Regions
• 5.3 North America Anti-Cancer Drug Market Analysis
  • 5.3.1 North America Anti-Cancer Drug Production
  • 5.3.2 North America Anti-Cancer Drug Revenue
  • 5.3.3 Key Manufacturers in North America
  • 5.3.4 North America Anti-Cancer Drug Import and Export
• 5.4 Europe Anti-Cancer Drug Market Analysis
  • 5.4.1 Europe Anti-Cancer Drug Production
  • 5.4.2 Europe Anti-Cancer Drug Revenue
  • 5.4.3 Key Manufacturers in Europe
  • 5.4.4 Europe Anti-Cancer Drug Import and Export
• 5.5 China Anti-Cancer Drug Market Analysis
  • 5.5.1 China Anti-Cancer Drug Production
  • 5.5.2 China Anti-Cancer Drug Revenue
  • 5.5.3 Key Manufacturers in China
  • 5.5.4 China Anti-Cancer Drug Import and Export
• 5.6 Japan Anti-Cancer Drug Market Analysis
  • 5.6.1 Japan Anti-Cancer Drug Production
  • 5.6.2 Japan Anti-Cancer Drug Revenue
  • 5.6.3 Key Manufacturers in Japan
  • 5.6.4 Japan Anti-Cancer Drug Import and Export
• 5.7 Southeast Asia Anti-Cancer Drug Market Analysis
  • 5.7.1 Southeast Asia Anti-Cancer Drug Production
  • 5.7.2 Southeast Asia Anti-Cancer Drug Revenue
  • 5.7.3 Key Manufacturers in Southeast Asia
  • 5.7.4 Southeast Asia Anti-Cancer Drug Import and Export
• 5.8 India Anti-Cancer Drug Market Analysis
  • 5.8.1 India Anti-Cancer Drug Production
  • 5.8.2 India Anti-Cancer Drug Revenue
  • 5.8.3 Key Manufacturers in India
  • 5.8.4 India Anti-Cancer Drug Import and Export

6 Anti-Cancer Drug Segment Market Analysis (by Type)

• 6.1 Global Anti-Cancer Drug Production by Type
• 6.2 Global Anti-Cancer Drug Revenue by Type
• 6.3 Anti-Cancer Drug Price by Type

7 Anti-Cancer Drug Segment Market Analysis (by Application)

• 7.1 Global Anti-Cancer Drug Consumption by Application
• 7.2 Global Anti-Cancer Drug Consumption Market Share by Application (2014-2019)

8 Anti-Cancer Drug Major Manufacturers Analysis

• 8.1 Merck
  • 8.1.1 Merck Anti-Cancer Drug Production Sites and Area Served
  • 8.1.2 Merck Product Introduction, Application and Specification
  • 8.1.3 Merck Anti-Cancer Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.1.4 Main Business and Markets Served
• 8.2 Bristol-Myers Squibb
  • 8.2.1 Bristol-Myers Squibb Anti-Cancer Drug Production Sites and Area Served
  • 8.2.2 Bristol-Myers Squibb Product Introduction, Application and Specification
  • 8.2.3 Bristol-Myers Squibb Anti-Cancer Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.2.4 Main Business and Markets Served
• 8.3 Bayer
  • 8.3.1 Bayer Anti-Cancer Drug Production Sites and Area Served
  • 8.3.2 Bayer Product Introduction, Application and Specification
  • 8.3.3 Bayer Anti-Cancer Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.3.4 Main Business and Markets Served
• 8.4 GlaxoSmithKline
  • 8.4.1 GlaxoSmithKline Anti-Cancer Drug Production Sites and Area Served
  • 8.4.2 GlaxoSmithKline Product Introduction, Application and Specification
  • 8.4.3 GlaxoSmithKline Anti-Cancer Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.4.4 Main Business and Markets Served
• 8.5 Novartis
  • 8.5.1 Novartis Anti-Cancer Drug Production Sites and Area Served
  • 8.5.2 Novartis Product Introduction, Application and Specification
  • 8.5.3 Novartis Anti-Cancer Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.5.4 Main Business and Markets Served
• 8.6 Sanofi
  • 8.6.1 Sanofi Anti-Cancer Drug Production Sites and Area Served
  • 8.6.2 Sanofi Product Introduction, Application and Specification
  • 8.6.3 Sanofi Anti-Cancer Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.6.4 Main Business and Markets Served
• 8.7 Pfizer
  • 8.7.1 Pfizer Anti-Cancer Drug Production Sites and Area Served
  • 8.7.2 Pfizer Product Introduction, Application and Specification
  • 8.7.3 Pfizer Anti-Cancer Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.7.4 Main Business and Markets Served
• 8.8 Amgen
  • 8.8.1 Amgen Anti-Cancer Drug Production Sites and Area Served
  • 8.8.2 Amgen Product Introduction, Application and Specification
  • 8.8.3 Amgen Anti-Cancer Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.8.4 Main Business and Markets Served
• 8.9 Celgene Corporation
  • 8.9.1 Celgene Corporation Anti-Cancer Drug Production Sites and Area Served
  • 8.9.2 Celgene Corporation Product Introduction, Application and Specification
  • 8.9.3 Celgene Corporation Anti-Cancer Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.9.4 Main Business and Markets Served
• 8.10 Ariad Pharmaceuticals
  • 8.10.1 Ariad Pharmaceuticals Anti-Cancer Drug Production Sites and Area Served
  • 8.10.2 Ariad Pharmaceuticals Product Introduction, Application and Specification
  • 8.10.3 Ariad Pharmaceuticals Anti-Cancer Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.10.4 Main Business and Markets Served
• 8.11 Eli Lilly
• 8.12 Hoffmann-La Roche Ltd.
• 8.13 AstraZeneca
• 8.14 Boehringer Ingelheim GmbH
• 8.15 Teva Pharmaceuticals

9 Development Trend of Analysis of Anti-Cancer Drug Market

• 9.1 Global Anti-Cancer Drug Market Trend Analysis
  • 9.1.1 Global Anti-Cancer Drug Market Size (Volume and Value) Forecast 2019-2025
• 9.2 Anti-Cancer Drug Regional Market Trend
  • 9.2.1 North America Anti-Cancer Drug Forecast 2019-2025
  • 9.2.2 Europe Anti-Cancer Drug Forecast 2019-2025
  • 9.2.3 China Anti-Cancer Drug Forecast 2019-2025
  • 9.2.4 Japan Anti-Cancer Drug Forecast 2019-2025
  • 9.2.5 Southeast Asia Anti-Cancer Drug Forecast 2019-2025
  • 9.2.6 India Anti-Cancer Drug Forecast 2019-2025
• 9.3 Anti-Cancer Drug Market Trend (Product Type)
• 9.4 Anti-Cancer Drug Market Trend (Application)
• 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
• 10.3 Anti-Cancer Drug Customers

11 Market Dynamics

• 11.1 Market Trends
• 11.2 Opportunities
• 11.3 Market Drivers
• 11.4 Challenges
• 11.5 Influence Factors

12 Conclusion

13 Appendix

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List